Nur Nicholson, Chief Technical Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 22,440 shares at $58.13 ($1.3M) on 2024-03-13, disclosed to the SEC on 2024-03-14.
Open-market sale of $1.3M APLS by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.31 | 7,768 | $445K | 34.5% |
| 2 | $57.31 | 7,768 | $445K | 34.5% |
| 3 | $58.13 | 3,452 | $201K | 15.5% |
| 4 | $58.13 | 3,452 | $201K | 15.5% |
| Total | $57.56 avg | 22,440 | $1.3M | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $58K | — | Filing → |
| APLS | SELL | 2025-01-30 | $24K | — | Filing → |
| APLS | SELL | 2025-01-23 | $240K | — | Filing → |